Oncogenic transgelin-2 is differentially regulated in isocitrate dehydrogenase wild-type vs. mutant gliomas

The presence of an isocitrate dehydrogenase (IDH1/2) mutation in gliomas is associated with favorable outcomes compared to gliomas without the mutation (IDH1/2 wild-type, WT). The underlying biological mechanisms accounting for improved clinical outcomes in IDH1/2 mutant gliomas remain poorly unders...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Beyer, Sasha J., Bell, Erica H., McElroy, Joseph P., Fleming, Jessica L., Cui, Tiantian, Becker, Aline, Bassett, Emily, Johnson, Benjamin, Gulati, Pooja, Popp, Ilinca, Staszewski, Ori, Prinz, Marco, Grosu, Anca L., Haque, Saikh Jaharul, Chakravarti, Arnab
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2018
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324682/
https://ncbi.nlm.nih.gov/pubmed/30647847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26365
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares